Nolain, Patrick
Djebli, Nassim
Brunet, Aurélie
Fabre, David
Khier, Sonia http://orcid.org/0000-0001-6712-8461
Article History
Accepted: 5 July 2022
First Online: 16 August 2022
Declarations
:
: This study was funded by Sanofi.
: The authors have no conflicts of interest.
: All procedures of studies were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Clinical study transparency was based on high ethical standards and norms and was consistent with all relevant national and regional regulations and laws and declared with following official number: NCT01026597, NCT01074372, NCT01161082, NCT01448317, NCT01723735, NCT01288443, NCT01288469, NCT01266876, NCT01644474, NCT01623115, NCT01644188, NCT01812707, and NCT01507831.
: Subjects provided written informed consent in all included studies.
: Not applicable.
: On demand (email: David.Fabre@sanofi.com).
: On demand (email: David.Fabre@sanofi.com).
: P.N. was responsible for the literature review, data analysis, and data interpretation. P.N. and S.K. drafted the manuscript, tables, and the figures. N.D. and D.F. were responsible for the review of PK analyses. N.D., D.F., A.B., and S.K. were responsible for the final review of the manuscript.